» Articles » PMID: 20723767

A Practical Guide to Understanding Kaplan-Meier Curves

Overview
Publisher Wiley
Date 2010 Aug 21
PMID 20723767
Citations 296
Authors
Affiliations
Soon will be listed here.
Abstract

In 1958, Edward L. Kaplan and Paul Meier collaborated to publish a seminal paper on how to deal with incomplete observations. Subsequently, the Kaplan-Meier curves and estimates of survival data have become a familiar way of dealing with differing survival times (times-to-event), especially when not all the subjects continue in the study. "Survival" times need not relate to actual survival with death being the event; the "event" may be any event of interest. Kaplan-Meier analyses are also used in nonmedical disciplines. The purpose of this article is to explain how Kaplan-Meier curves are generated and analyzed. Throughout this article, we will discuss Kaplan-Meier estimates in the context of "survival" before the event of interest. Two small groups of hypothetical data are used as examples in order for the reader to clearly see how the process works. These examples also illustrate the crucially important point that comparative analysis depends upon the whole curve and not upon isolated points.

Citing Articles

Prognostic significance and immune microenvironment infiltration patterns of hypoxia and endoplasmic reticulum stress-related genes in gastric cancer.

Li L, Liang Y, Xu W Front Oncol. 2025; 15:1542740.

PMID: 40061897 PMC: 11885130. DOI: 10.3389/fonc.2025.1542740.


Assessment of Antimicrobial Therapy in Eradicating Chlamydia muridarum in Research Mice: Immune Status and Its Impact on Outcomes.

Palillo M, Carrasco S, Mishkin N, Palillo J, Lynch D, Lawton S J Am Assoc Lab Anim Sci. 2025; 64(1):76-88.

PMID: 40035285 PMC: 11808367. DOI: 10.30802/AALAS-JAALAS-24-069.


TCGEx: a powerful visual interface for exploring and analyzing cancer gene expression data.

Kus M, Sahin C, Kilic E, Askin A, Ozgur M, Karahanogullari G EMBO Rep. 2025; .

PMID: 40033050 DOI: 10.1038/s44319-025-00407-7.


Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes.

Liu B, Ao Y, Liu C, Bai F, Zhou Z, Huang J Front Oncol. 2025; 15:1485421.

PMID: 40018411 PMC: 11864952. DOI: 10.3389/fonc.2025.1485421.


Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors.

Lin Y, Li H, Ge Q, Hua D Transl Cancer Res. 2025; 14(1):240-253.

PMID: 39974385 PMC: 11833365. DOI: 10.21037/tcr-24-1035.


References
1.
Henschke C, Yankelevitz D, Libby D, Pasmantier M, Smith J, Miettinen O . Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355(17):1763-71. DOI: 10.1056/NEJMoa060476. View

2.
Carter R, Huang P . Cautionary note regarding the use of CIs obtained from Kaplan-Meier survival curves. J Clin Oncol. 2008; 27(2):174-5. DOI: 10.1200/JCO.2008.18.8011. View